Endréné Magyari

Title: Endréné Magyari: Innovator in Pharmaceutical Synthesis

Introduction

Endréné Magyari is a notable inventor based in Albertirsa, Hungary. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of innovative processes for creating important compounds.

Latest Patents

Magyari holds 2 patents that focus on advanced industrial processes. His latest patents include an industrial process for the synthesis of 17α-acetoxy-11β-[4-(N,N-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione, which is recognized for its strong antiprogestogenic and antiglucocorticoid properties. Additionally, he has developed a new industrial process for synthesizing solvate-free 17α-acetoxy-11β-[4-(N,N-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione [CDB-2914]. This invention also encompasses compounds used as intermediates in the synthesis process.

Career Highlights

Throughout his career, Magyari has worked with prominent companies in the pharmaceutical industry, including Richter Gedeon Vegyeszeti Gyar Rt and Richter Gedeon Nyrt. His work has significantly impacted the development of pharmaceutical compounds and processes.

Collaborations

Magyari has collaborated with esteemed colleagues such as Zoltán Tuba and Sándor Mahó, contributing to the advancement of innovative pharmaceutical solutions.

Conclusion

Endréné Magyari's contributions to pharmaceutical synthesis through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of important pharmaceutical agents.